News
Reappointments to the Board of National Cancer Registry Ireland
From Department of Health
Published on
Last updated on
From Department of Health
Published on
Last updated on
Dr Jerome Coffey
Dr Jerome Coffey was appointed Chairperson of the Board of the National Cancer Registry in May 2017. Dr Coffey is also the former Director of the National Cancer Control Programme (NCCP). A graduate of TCD he completed internal medicine and radiation oncology training in Ireland. Following higher training in major academic oncology centres in Canada and the UK he was appointed as a Consultant Radiation Oncologist to the staff of the St Luke’s Radiation Oncology Network and the Mater Misericordiae University Hospital in 2006. Before taking up his current role he was Clinical Director of the St Luke’s Radiation Oncology Network, Chairman of the Radiation Oncology Committee in the Faculty of Radiologists (RCSI) and Radiation Oncology Advisor to the NCCP.
Dr Coffey is reappointed as Chairperson from 15 February 2021 to 14 February 2025.
Dr Catherine Kelly
Dr Catherine M. Kelly is a Consultant Oncologist at the Mater Misericordiae University Hospital, Dublin and a Clinical Lecturer at University College Dublin (UCD). Dr Kelly is a member of the Board of Cancer Trials Ireland and joint chair of its Breast Cancer Disease Specific Sub-Group. She received higher specialist training in oncology in St Bartholomew’s London, UK, The Sunnybrook Odette Cancer Center, Toronto, Ontario, Canada, and was the Susan G. Komen Fellow, MD Anderson Cancer Center, Houston, TX, USA. Dr Cathy Kelly received an MSc in Clinical Epidemiology from the Institute of Health Policy, Management and Evaluation, University of Toronto and received the Thomas & Edna Naylor Memorial Award from the University of Toronto for research using Ontario Cancer Registry and other population-based data. Dr Kelly’s recent peer reviewed publications have focused on personalised medicine, breast cancer genomics and clinical trial design. She serves on the editorial boards for several oncology journals including the Journal of Clinical Oncology (JCO) editorial advisory board.
Dr Kelly is reappointed from 15 February 2021 to 14 February 2022.